Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer

NCT05288777 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.

NCT NCT05288777
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05288777 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer
Lead sponsor
University of Virginia
Phase
Phase 2/3
Overall status
Recruiting
Start date
July 11, 2022
Completion date
December 31, 2029
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast cancer stage i, breast cancer stage ii, breast cancer stage iii